Published in Science on April 07, 1967
Rethinking the emotional brain. Neuron (2012) 3.19
Relationship between plasma level and therapeutic effect of nortriptyline. Br Med J (1971) 2.19
Correlation of subjective side effects with plasma concentrations of nortriptyline. Br Med J (1970) 2.13
Effects of chronic antidepressant drug administration and electroconvulsive shock on activity of dopaminergic neurons in the ventral tegmentum. Int J Neuropsychopharmacol (2010) 1.46
Lithium treatment for psychiatric disorders. West J Med (1978) 1.41
A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat. Proc Natl Acad Sci U S A (1967) 1.23
Exercise therapy in coronary disease. Bull N Y Acad Med (1968) 1.17
Deep brain stimulation for treatment-resistant depression: systematic review of clinical outcomes. Neurotherapeutics (2014) 1.12
Revitalizing psychiatric therapeutics. Neuropsychopharmacology (2014) 1.05
Some evidence for the involvement of adrenergic sites in the memory trace. Proc Natl Acad Sci U S A (1970) 1.04
The genetics of major depression: moving beyond the monoamine hypothesis. Psychiatr Clin North Am (2010) 1.00
Toward an integration of cognitive and genetic models of risk for depression. Cogn Emot (2012) 0.99
Ketamine and phencyclidine: the good, the bad and the unexpected. Br J Pharmacol (2015) 0.97
Mechanistic role for a novel glucocorticoid-KLF11 (TIEG2) protein pathway in stress-induced monoamine oxidase A expression. J Biol Chem (2012) 0.96
Physiological and drug-induced changes in the glycogen content of mouse brain. Br J Pharmacol (1970) 0.96
Effects of intraventricular 2,4,5-trihydroxyphenylethylamine (6-hydroxydopamine) on rat behaviour and brain catecholamine metabolism. Br J Pharmacol (1970) 0.95
Genetic variation in activity of enzymes involved in synthesis of catecholamines. Proc Natl Acad Sci U S A (1972) 0.95
Behavioral activation of rats during intraventricular infusion of norepinephrine. Proc Natl Acad Sci U S A (1970) 0.93
L-dopa and arousal. J Neurol Neurosurg Psychiatry (1974) 0.93
Norepinephrine neuronal uptake binding sites in rat brain membranes labeled with [3H]desipramine. Proc Natl Acad Sci U S A (1981) 0.86
Structure-activity relations for the inhibition of 5-hydroxytryptamine uptake by tricyclic antidepressants into synaptosomes from serotoninergic neurones in rat brain homogenates. Br J Pharmacol (1974) 0.86
Effect of receptor blocking drugs on the depletion of brain glycogen by amphetamine. Br J Pharmacol (1971) 0.84
Amines and abnormal mood. Proc R Soc Med (1969) 0.83
A mitochondrial bioenergetic basis of depression. J Bioenerg Biomembr (2014) 0.81
ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence. Prog Neuropsychopharmacol Biol Psychiatry (2014) 0.81
Functional genetic variants in the vesicular monoamine transporter 1 modulate emotion processing. Mol Psychiatry (2013) 0.81
A taxonomic study of physiological responses to a psychological stress. J Neurol Neurosurg Psychiatry (1970) 0.80
Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain. Depress Res Treat (2011) 0.78
Influence of chronic administration of antidepressant drugs on mRNA for galanin, galanin receptors, and tyrosine hydroxylase in catecholaminergic and serotonergic cell-body regions in rat brain. Neuropeptides (2012) 0.78
Reduction of norepinephrine in the lower brainstem by psychological stimulus. Proc Natl Acad Sci U S A (1968) 0.78
Local and Global Resting State Activity in the Noradrenergic and Dopaminergic Pathway Modulated by Reboxetine and Amisulpride in Healthy Subjects. Int J Neuropsychopharmacol (2015) 0.76
Iatrogenic hypothyroid psychosis. Br Med J (1969) 0.75
Neurochemistry and behavior in man. West J Med (1976) 0.75
Psychic stress as a trigger of the spontaneous development and rupture of an aneurysm? A case report. Interv Neuroradiol (2001) 0.75
Floyd Bloom Discusses the Messengers of the Mind. eNeuro (2014) 0.75
Neuromodulation, Emotional Feelings and Affective Disorders. Mens Sana Monogr (2016) 0.75
Seeking common ground in contemporary psychiatry. Proc R Soc Med (1969) 0.75
From Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder. Front Cell Neurosci (2017) 0.75
The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry (1965) 5.09
THE EFFECT OF BILATERAL STELLATE GANGLION BLOCK ON THE CEREBRAL CIRCULATION IN NORMOTENSIVE AND HYPERTENSIVE PATIENTS. J Clin Invest (1949) 2.84
Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite. Biochem Pharmacol (1968) 1.86
The effects of psychoactive drugs on norepinephrine-3-H metabolism in brain. Biochem Pharmacol (1967) 1.54
THE TOXIC FACTORS IN EXPERIMENTAL TRAUMATIC SHOCK. IV. THE EFFECTS OF THE INTRAVENOUS INJECTION OF THE EFFUSION FROM ISCHEMIC MUSCLE. J Clin Invest (1945) 1.54
The adopted-away offspring of schizophrenics. Am J Psychiatry (1971) 1.53
THE TOXIC FACTORS IN EXPERIMENTAL TRAUMATIC SHOCK. I. PHYSIOLOGIC EFFECTS OF MUSCLE LIGATION IN THE DOG. J Clin Invest (1945) 1.49
Mental illness in the biological and adoptive families of adopted individuals who have become schizophrenic: a preliminary report based on psychiatric interviews. Proc Annu Meet Am Psychopathol Assoc (1975) 1.36
Measurement of regional cerebral blood flow with antipyrine-14C in awake cats. J Appl Physiol (1969) 1.35
THE TOXIC FACTORS IN EXPERIMENTAL TRAUMATIC SHOCK. V. CHEMICAL AND ENZYMATIC PROPERTIES OF MUSCLE EXUDATE. J Clin Invest (1945) 1.33
Effects of stress on the metabolism of norepinephrine, dopamine and serotonin in the central nervous system of the rat. I. Modifications of norepinephrine turnover. J Pharmacol Exp Ther (1968) 1.33
Psychiatric disorders in the biological and adoptive families of adopted individuals with affective disorders. Arch Gen Psychiatry (1986) 1.27
A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat. Proc Natl Acad Sci U S A (1967) 1.23
Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? Harv Rev Psychiatry (1999) 1.21
The catecholamine hypothesis of affective disorders: a review of supporting evidence. 1965. J Neuropsychiatry Clin Neurosci (1995) 1.14
The current status of biological criteria for classifying the depressive disorders and predicting responses to treatment. Psychopharmacol Bull (1974) 1.06
Mental illness in the biological and adoptive relatives of schizophrenic adoptees: findings relevant to genetic and environmental factors in etiology. Am J Psychiatry (1983) 1.05
Current biochemical approaches to schizophrenia. N Engl J Med (1967) 1.04
Mental illness in the biological and adoptive families of adopted individuals who have become schizophrenic. Behav Genet (1976) 1.04
Observations on the validity of a two compartmental model of the cerebral circulation. Acta Neurol Scand Suppl (1965) 1.02
THE TOXIC FACTORS IN EXPERIMENTAL TRAUMATIC SHOCK. II. STUDIES ON ELECTROLYTE AND WATER BALANCE IN SHOCK. J Clin Invest (1945) 1.01
Parent-child relationships and psychopathological disorder in the child. Arch Gen Psychiatry (1975) 1.01
Increase in rat brain tyrosine hydroxylase activity produced by electroconvulsive shock. Proc Natl Acad Sci U S A (1969) 1.00
Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings. Am J Psychiatry (1973) 0.99
Schizotypal personality disorder: an operational definition of Bleuler's latent schizophrenia? Schizophr Bull (1985) 0.98
Mental illness in the biological and adoptive families of adpoted schizophrenics. Am J Psychiatry (1971) 0.98
Diurnal variation of plasma cortisol and homovanillic acid in healthy subjects. Psychoneuroendocrinology (1996) 0.97
Normetanephrine excretion and affective state in depressed patients treated with imipramine. Am J Psychiatry (1966) 0.97
Amphetamine withdrawal: affective state, sleep patterns, and MHPG excretion. Am J Psychiatry (1972) 0.96
Catecholamines in neuropsychiatric states. Pharmacol Rev (1966) 0.93
The effects of delta-9-tetrahydrocannabinol on the metabolism of norepinephrine in rat brain. Psychopharmacologia (1971) 0.93
Amphetamine withdrawal: effects on threshold of intracranial reinforcement. Psychopharmacology (Berl) (1981) 0.92
The syndrome of schizophrenia: unresolved questions and opportunities for research. Br J Psychiatry (1980) 0.92
Tranylcypromine: effects on norepinephrine metabolism in rat brain. Am J Psychiatry (1970) 0.91
Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action. Am J Psychiatry (1967) 0.91
Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis. Neurology (1988) 0.89
Neuropharmacology of the affective disorders. Annu Rev Pharmacol (1973) 0.89
Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study. J Clin Psychopharmacol (1985) 0.89
Desynchronized sleep and MHPG excretion: an inverse correlation. Brain Res (1973) 0.88
Crossfostering. A research strategy for clarifying the role of genetic and experiential factors in the etiology of schizophrenia. Arch Gen Psychiatry (1974) 0.88
Disorders of the human brain. Sci Am (1979) 0.88
Biogenic amines and affective disorders. Annu Rev Med (1974) 0.87
Study of the cerebral circulation by means of inert diffusible tracers. Prog Brain Res (1972) 0.87
Alterations in brain norepinephrine metabolism induced by environmental stimuli previously paired with inescapable shock. Science (1980) 0.86
Studies based on a total sample of adopted individuals and their relatives: why they were necessary, what they demonstrated and failed to demonstrate. Schizophr Bull (1976) 0.86
Social class and psychopathology in adoptees. A natural experimental method for separating the roles of genetic and experimential factors. Arch Gen Psychiatry (1973) 0.86
Biochemistry and mental function. Nature (1965) 0.86
The possible role of the adrenergic systems of the cortex in learning. Res Publ Assoc Res Nerv Ment Dis (1972) 0.85
Toward a biochemical classification of depressive disorders--VIII. Platelet monoamine oxidase activity in subtypes of depressions. J Psychiatr Res (1985) 0.85
Effects of 6-hydroxydopamine on sleep in the rat. Nature (1971) 0.85
Should clozapine be a first-line treatment for schizophrenia? The rationale for a double-blind clinical trial in first-episode patients. Harv Rev Psychiatry (1997) 0.85
Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions. Arch Gen Psychiatry (1978) 0.84
Alpha-methylparatyrosine and sleep in the rat. Psychopharmacologia (1971) 0.83
The effects of tranylcypromine isomers on norepinephrine-H3 metabolism in rat brain. Psychopharmacology (Berl) (1980) 0.83
From rationalization to reason. Am J Psychiatry (1974) 0.83
Some aspects of adoption in selected samples of adult adoptees. Am J Orthopsychiatry (1976) 0.82
Amphetamine withdrawal: depression and M.H.P.G. excretion. Lancet (1971) 0.82
Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine. J Psychiatr Res (1965) 0.82
Studies designed to disentangle genetic and environmental variables in schizophrenia: some epistemological questions and answers. Am J Psychiatry (1976) 0.82
Catecholamine metabolism in affective disorders. IV. Preliminary studies of norepinephrine metabolism in depressed patients treated with amitriptyline. J Psychiatr Res (1972) 0.82
Alterations in brain norepinephrine metabolism and behavior induced by environmental stimuli previously paired with inescapable shock. Behav Brain Res (1981) 0.81
Late feedback effects of hypothalamic-pituitary-adrenal axis hormones in healthy subjects. Psychoneuroendocrinology (1998) 0.81
Hypothalamic-pituitary-adrenal axis activity and 1-year outcome in depression. Biol Psychiatry (1993) 0.81
Norepinephrine metabolism in the rat brain following acute and chronic administration of thyrotropin releasing hormone. Psychopharmacologia (1974) 0.81
Abnormal flash visual evoked response in melancholia: a replication study. Biol Psychiatry (1992) 0.81
Effects of tricyclic antidepressants on the uptake and mabolism of intracisternally administered norepinephrine-H3 in rat brain. J Psychiatr Res (1969) 0.81
Clinical utility of tricyclic antidepressant blood levels: a case report. Am J Psychiatry (1979) 0.81
Norepinephrine turnover and metabolism in rat brain after long-term administration of imipramine. Science (1970) 0.81
The effects of pentobarbital on the fate of intracisternally administered norepinephrine-H3. J Pharmacol Exp Ther (1967) 0.80
Julius H. Comroe, Jr.: March 13, 1911-July 31, 1984. Biogr Mem Natl Acad Sci (2001) 0.80
Changes in norepinephrine output following light therapy for fall/winter seasonal depression. Biol Psychiatry (1992) 0.80
The catecholamine hypothesis of affective disorders. A review of supporting evidence. Int J Psychiatry (1967) 0.80
Biochemical criteria for classifying depressive disorders and predicting responses to pharmacotherapy: preliminary findings from studies of norepinephrine metabolism. Contributions to biochemistry. Pharmakopsychiatr Neuropsychopharmakol (1974) 0.80
Signal transduction by platelet adenylate cyclase: alterations in depressed patients may reflect impairment in the coordinated integration of cellular signals (coincidence detection). Biol Psychiatry (1998) 0.79
The psychiatric adjustment of the adopting parents of schizophrenics. Am J Psychiatry (1971) 0.79
The effects of lithium ion on H3-norepinephrine metabolism in brain. Life Sci (1966) 0.79
Regional cerebral blood flow: estimation by means of nonmetabolized diffusible tracers--an overview. Semin Nucl Med (1985) 0.79
Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients. Am J Psychiatry (1976) 0.79
Effects of psychoactive drugs on the metabolism of intracisternally administered serotonin in rat brain. Biochem Pharmacol (1969) 0.79
Changes in norepinephrine turnover in rat brain during chronic administration of imipramine and protriptyline: a possible explanation for the delay in onset of clinical antidepressant effects. Am J Psychiatry (1971) 0.78
Ralph Waldo Gerard: October 7, 1900-February 17, 1974. Biogr Mem Natl Acad Sci (1982) 0.78
Adoption studies of schizophrenia. Am J Med Genet (2000) 0.78
Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate. J Psychiatr Res (1970) 0.78
Rapid antidepressant response to alprazolam in depressed patients with high catecholamine output and heterologous desensitization of platelet adenylate cyclase. Biol Psychiatry (1988) 0.78
Biochemistry and mental states. Calif Med (1968) 0.78
M.H.P.G. excretion and clinical classification in depressive disorders. Lancet (1973) 0.77
Toward a biochemical classification of depressive disorders, V: Heterogeneity of unipolar depressions. Am J Psychiatry (1982) 0.77
Determination of urinary normetanephrine and metanephrine by radial-compression liquid chromatography and electrochemical detection. Clin Chem (1983) 0.77
Amphetamine withdrawal: effects on brain levels of MHPG-SO4 in the rat. Commun Psychopharmacol (1979) 0.77
Toward a biochemical classification of depressive disorders. X. Urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders. Arch Gen Psychiatry (1989) 0.77
Norepinephrine content of various rat organs after chronic administration of desmethylimipramine. Arch Int Pharmacodyn Ther (1975) 0.77
Cortisol feedback effects on plasma corticotropin levels in healthy subjects. Psychoneuroendocrinology (1997) 0.77
[Regional measurements of cerebral blood blow by recording in depth of hydrogen "clearance" curves]. Boll Soc Ital Biol Sper (1964) 0.77
Personal and social characteristics differentiating adoptive relatives of schizophrenics and nonschizophrenics: a preliminary report based on interviews. Compr Psychiatry (1979) 0.77
Clozapine response and plasma catecholamines and their metabolites. Psychiatry Res (1993) 0.77
Platelet MAO activity and the dexamethasone suppression test in depressed patients. Am J Psychiatry (1983) 0.77
Toward hypotheses for a biochemical component in the vulnerability to schizophrenia. Semin Psychiatry (1972) 0.76
Genetic: environmental interactions in schizophrenia. Trans Stud Coll Physicians Phila (1970) 0.76
Recent approaches to the measurement of cerebral blood flow and their underlying principles. Res Publ Assoc Res Nerv Ment Dis (1966) 0.76
Toward a biochemical classification of depressive disorders IV: Pretreatment urinary MHPG levels as predictors of antidepressant response to imipramine. Commun Psychopharmacol (1980) 0.76